
FDA Approves First Nonprescription Oral Contraceptive ‘Opill’
Dr. Ingrid Skop, an OB-GYN and director of medical affairs at the Charlotte Lozier Institute, said ‘there are several concerns with this progesterone-only formulation.’
Dr. Ingrid Skop, an OB-GYN and director of medical affairs at the Charlotte Lozier Institute, said ‘there are several concerns with this progesterone-only formulation.’
They echo other critics who say the drug’s side effects mean patients should have physician supervision while taking the drug.
A pro-life health organization, the Alliance for Hippocratic Medicine, filed a lawsuit against the FDA in Texas, which claims the FDA failed to abide by its legal obligations when approving the drug.
Yesterday’s policy change comes after a December 2021 change that permanently lifted the requirement for patients to obtain mifepristone during in-person appointments with a physician.
Signers of the letter include Marjorie Dannenfelser, president of the Susan B. Anthony List; Jeanne Mancini, president of March for Life; Catherine Glenn Foster, president and CEO of Americans United for Life; Ryan Bomberger, co-founder of the Radiance Foundation; and Russell Moore, president of the Southern Baptist Ethics and Religious Liberty Commission.
Legislators, pro-life groups and ethicists have condemned a new government contract to obtain tissue from aborted children.
The move from the Obama administration comes at a time when the abortion industry is facing pressure from state laws, and sees the market moving toward ‘medication abortions.’
Subscriber Service CenterAlready a subscriber? Renew or manage your subscription here.
Subscribe for just $49.95 $32.50!Start your Register subscription today.
Give a Gift SubscriptionBless friends, family or clergy with a gift of the Register.
Order NowOrder Bulk SubscriptionsGet a discount on 6 or more copies sent to your parish, organization or school.
Order NowSign-up for E-NewsletterGet Register Updates sent daily or weeklyto your inbox.
Sign Up